SCHEMBL8583282

SCHEMBL8583282

C=C1SC(=S)N(c2cc(-c3ccccc3SC)c(O)c(C(C)(C)C)c2)C1=O

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.33
PTGS2 P35354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8709018 0.82 KMT2A (0.35)
SCHEMBL8582964 0.81 PTGS2 (0.39) PTGS2
SCHEMBL8579119 0.77 CYP1A2 (0.40) PTGS2
SCHEMBL8583284 0.77 PTGS2 (0.31) PTGS2
SCHEMBL8583061 0.72 HSPA5 (0.32) PTGS2
SCHEMBL14853306 0.71 HSP90AA1 (0.46) PTPN1PTGS2
SCHEMBL8708475 0.70 PTGS2 (0.40) PTGS2
SCHEMBL8911876 0.69 CA2 (0.39) PTGS2
SCHEMBL8306585 0.68 PTGS2 (0.69) PTGS2
SCHEMBL8306587 0.68 PTGS2 (0.69) PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5731336-A USING ARYL-SUBSTITUTED RHODAMINES ELI LILLY AND COMPANY (US) 1998-03-24 US disclosed
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed